lim-0705

Small moleculeexperimental

Clinical trial activity

3 trials · 3 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Feb 1, 2010 (NCT01060475)

Timeline

2010s

  1. Jan 1, 2010

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2011

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • lim-0705
  • lim-0705

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01364155Phase 2May 1, 2011Limerick BioPharma, Profil GmbH
NCT01093677Phase 1Mar 1, 2010Limerick BioPharma, Nucleus Network Ltd
NCT01060475Phase 1Feb 1, 2010Limerick BioPharma, Nucleus Network Ltd
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (3)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Limerick BioPharmaFor profit3322010
Nucleus Network LtdFor profit2012010
Profil GmbHFor profit1012011
3 organizations
Page 1 / 1